High Tide (HITI) Q3 2026 Earnings Call Transcript
High Tide (HITI) reported Q3 2026 revenue of $198.8M, up 33% YoY, with record net income of $12.7M. Adjusted EBITDA rose 53% YoY to $16.2M. The company expanded its store count to 232 locations in Canada and saw significant growth in its German medical cannabis operations through Remexian. Management highlighted strong free cash flow and strategic plans for market expansion, while noting risks from macroeconomic uncertainty and competitive pressures.
How this was made

The 30-second read
Why it matters
The earnings beat showcases strong top-line growth and record profitability, likely to influence short-term price action.
Market read
First report of HITI's Q3 results provides fresh data for traders assessing the cannabis sector and potential upside for the stock.
What to watch
Potential regulatory risk from U.S. cannabis rescheduling and import quota volatility in Germany.
Background
High Tide Inc. (NASDAQ:HITI) reported its Q3 2026 earnings via a conference call, detailing financial and operational performance.
Ticker impact
Quarterly earnings released with record revenue and profit metrics, including $198.8M revenue and $12.7M net income.
Potential upside as investors price in higher growth and cash flow.
First disclosure of Q3 2026 results shows 33% revenue growth and record profitability, likely to drive buying pressure.
Market effects
Highlights strength in the Canadian cannabis retail sector and growing medical cannabis demand in Germany.
May boost sentiment for other North American cannabis firms and European medical cannabis distributors.
Adds to broader discussion on cannabis legalization and potential U.S. schedule changes.
Counterpoint
Valuation may already price in growth; rapid expansion could strain margins if competition intensifies.
Key entities
- ExecutiveRaj Grover
President and CEO of High Tide Inc.
- ExecutiveMayank Mahajan
Chief Financial Officer of High Tide Inc.




